Penumbra
PEN
#1771
Rank
A$14.77 B
Marketcap
$385.03
Share price
-0.08%
Change (1 day)
0.86%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.60 Billion

According to Penumbra's latest financial reports the company's total liabilities are A$0.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.55 B1.31%
2022-12-31A$0.54 B36.92%
2021-12-31A$0.39 B66.14%
2020-12-31A$0.24 B-6.29%
2019-12-31A$0.25 B95.2%
2018-12-31A$0.13 B34.51%
2017-12-31A$97.68 M68.82%
2016-12-31A$57.86 M34.54%
2015-12-31A$43 M-73.63%
2014-12-31A$0.16 B83.67%
2013-12-31A$88.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.42 B-29.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.68 B 181.37%๐Ÿ‡บ๐Ÿ‡ธ USA